Effect of Everolimus (RAD001) on Acute Graft-Versus-Host Disease in Mice

J Pediatr Hematol Oncol. 2016 Nov;38(8):663-664. doi: 10.1097/MPH.0000000000000622.

Authors

Dae Seong Kim¹, Yoo Jin Park, Myoung Woo Lee, Hyun Jin Park, Hye Lim Jung, Ki Woong Sung, Hong Hoe Koo, Keon Hee Yoo

Affiliation

¹ *Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine †Stem Cell & Regenerative Medicine Center, Research Institute for Future Medicine, Samsung Medical Center Departments of ‡Health Sciences and Technology §Medical Device Management and Research, SAIHST, Sungkyunkwan University, Seoul, Korea.

PMID: 27379528
DOI: 10.1097/MPH.0000000000000622

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Everolimus / pharmacology*
Graft vs Host Disease / drug therapy*
Hematopoietic Stem Cell Transplantation / adverse effects*
Heterografts
Humans
Immunosuppressive Agents / pharmacology*
Mice, Inbred NOD
Mice, SCID

Substances

Immunosuppressive Agents
Everolimus